Chicago
,
US
15 - 18 June 2023
Endocrine Society (ENDO 2023)
Presentation schedule and materials
The congress symposium is no longer available
Thursday, 15 June 2023
POSTER
Determination of Receptor Binding Affinity of Growth Hormone Analogues to the Growth Hormone Receptor in a Drug Screening Context
Simon Erlendsson1; Alina Kulakova1; Svend Poulsen1; Peter Thygesen1
POSTER
Somapacitan Administered Subcutaneously at 5 mg/1.5 mL or 10 mg/1.5 mL Strengths Yields Clinically Similar PK and IGF-I Profiles in Healthy Participants
Michael Højby Rasmussen1; Rasmus Juul Kildemoes1; Claus Sværke1
POSTER
Model-Based Analysis of IGF-I Response, Dosing, and Monitoring for Once-Weekly Somapacitan in Children with GH Deficiency
Rasmus Juul Kildemoes1; Yassine Kamal Lyauk1; Joanne C. Blair2; Bradley S. Miller3; Jun Mori4; Michael Højby Rasmussen1; Philippe F. Backeljauw5
POSTER
Coverage of Education and Training of Traumatic Brain Injury-Induced Growth Hormone Deficiency in US Endocrinology Fellowship Programs
Kevin Choong Ji Yuen1; Radhika Adiga2; Nicky Kelepouris3; Javier Cardenas4
Saturday, 17 June 2023
POSTER
Effective GH Replacement With Once-Weekly Somapacitan in Children With GH Deficiency: 2-Year Results From REAL4
Bradley S. Miller1; Joanne C. Blair2; Michael Højby Rasmussen3; Aristides Maniatis4; Jun Mori5; Volker Böttcher6; Ho-Seong Kim7; Rikke Beck Bang8; Michel Polak9; Reiko Horikawa10
POSTER
Patient Preference Questionnaire Response After Switching to Somapacitan After Taking Daily GH: 2-Year Results From REAL4
Joanne C. Blair1; Bradley S. Miller2; Michael Højby Rasmussen3; Aristides Maniatis4; Jun Mori5; Volker Böttcher6; Ho-Seong Kim7; Rikke Beck Bang8; Lasse De Fries Jensen9; Michel Polak9; Reiko Horikawa10
ORAL PRESENTATION
Pre-Treatment Blood Transcriptome Predicts First-year Growth and IGF-I Response to Somapacitan Treatment in Children with GH Deficiency
Terence Garner1; Peter Clayton1,2; Michael Højby3; Philip Murray1,2; Adam Stevens1
Keywords